Product analysis
St. John's Wort 300 mg offers focused herbal mood support, with benefits that depend on the preparation and individual situation. It can interact with many medicines, including contraceptives and blood thinners, so a pharmacist should check whether it is suitable for you.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality40
The extract is identified, but its quality cannot be compared confidently from the available detail. Naming a constituent alone does not establish equivalence with other extracts.
Ingredient Transparency100
The amount and named extract detail are disclosed. That makes the contents easier to identify when comparing preparations.
Value For Money40
There is not enough information to judge value confidently. A clear amount alone does not establish whether the extract is worth its cost.
Customer Satisfaction88
Customer ratings are strongly positive. The large review base gives a broader picture of customer satisfaction.
Product Focus67
The single herb keeps the formula focused on mood support. The serving is below the daily amounts in much of the relevant evidence, and benefits for healthy adults remain uncertain.
- Format
Capsule - Container
- 100 Capsule(s)
- Per serving
- $0.08
- Customer rating
- 4.6 · 10,490 ratings
Goals
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
St. John's Wort extract (Hypericin) | 300 mg |
How this ingredient is rated
Composition and Label Disclosure
Composition and Label Disclosure50
Explicit Label Detail
Commercial Price and Usability
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- St John's wort for major depression.
- Efficacy of St. John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial.
- A systematic review and meta-analysis of Hypericum perforatum in depression: a comprehensive clinical review.
- Efficacy and tolerability of hypericum extract WS 5572 versus placebo in mildly to moderately depressed patients. A randomized double-blind multicenter clinical trial.
- Complementary therapies for clinical depression: an overview of systematic reviews.